Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.
第一作者:
Paul N,Harden
第一单位:
Oxford Transplant Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
作者:
医学主题词
可行性研究(Feasibility Studies);移植物排斥(Graft Rejection);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肾移植(Kidney Transplantation);活体供者(Living Donors);监测, 免疫学(Monitoring, Immunologic);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory)
DOI
10.1111/ajt.16395
PMID
33171020
发布时间
2025-05-30
基金项目
MR/K025538/1/MRC_/Medical Research Council/United Kingdom
MR/N027930/1/MRC_/Medical Research Council/United Kingdom
211122/WT_/Wellcome Trust/United Kingdom
RG/13/12/30395/BHF_/British Heart Foundation/United Kingdom
211122/Z/18/Z/WT_/Wellcome Trust/United Kingdom
- 浏览1
American journal of transplantation
1603-1611页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



